Clinical trial
Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal…
NCT00223223 · University of Texas Southwestern Medical Center, Other · Completed
Key facts
| NCT number | NCT00223223 |
|---|---|
| Title | Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study |
| Official title | Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Memory Loss Associated With Corticosteroid Use, Manic State Associated With Corticosteroid Use |
| Intervention type | Drug |
| Interventions | Levetiracetam, Keppra |
| Enrollment | 30 |
| Start date | Feb 1, 2005 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 3, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: